|
Market Cap (5-Jul) $2,416,092 (1,016th) |
Close (30-Jun) $0.016 |
Volume (30-Jun) 5,525,026 |
Shortsold (24-Dec) 11,970 (0.01%) (590th) |
|
52w High $0.082 |
52w Low $0.011 |
P/E - |
EPS -0.05 |
IBX released this announcement to the ASX on 25 May 2022, 8:33. The announcement is not marked as price sensitive, and is 29 page(s) in length and 3.12MB in size.
You can view all announcements from IBX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IBX was 0.003% short sold according to ASIC data. It was ranked the 617th most shorted stock on the ASX. It is now ranked as the 590th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (24 December 2024).
| Other Recent Announcements from IBX | |
|---|---|
| Expanded collaboration with Siemens Healthineers to US | 28 June 2023, 8:49 |
| Imagion to complete the MagSense HER2 Phase 1 Study | 21 June 2023, 8:27 |
| Imagion Announces New CEO | 19 June 2023, 8:31 |
| AGM presentation | 25 May 2022, 8:33 |
| Chairman's Address to Shareholders AGM | 25 May 2022, 8:33 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2022, 9:09 |
| Notice of Annual General Meeting/Proxy Form | 22 April 2022, 8:50 |
You must be logged in to post a reply.
Imagion Biosystems 